Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iMerit is a private AI data solutions company that provides data annotation, model evaluation, model fine-tuning, and human-in-the-loop workflows for enterprise AI applications. The company serves multiple verticals including healthcare, where it supports medical imaging, pathology, radiology, medical text, clinical data, and pharmaceutical and life sciences use cases. Its Ango Hub platform combines workflow automation, annotation tooling, and quality-control capabilities, and iMerit also offers expert networks such as iMerit Scholars for generative AI development. In healthcare, the company positions itself as a services and platform provider rather than a therapeutic developer, offering HIPAA-compliant and GxP-aligned data operations for medical AI and life sciences customers. iMerit is therefore healthcare-related, but it is not a biotech or pharma pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iMerit.